Isospora Belli (Cystoisospora belli) and Cryptosporidium in HIV-Associated Diarrhea

PART 1: CYSTOISOSPORA BELLI (formerly Isospora belli)

Organism & Taxonomy

• There are no known non-human reservoir hosts - humans are the only known host
• Distribution: worldwide, predominantly tropical and subtropical regions (South America, Africa, Middle East, Southeast Asia)
• In North America, seen mainly in older children, institutionalized individuals, and immunocompromised patients

Life Cycle

Morphology

Epidemiology in HIV

• In the early AIDS epidemic, identified in < 3% of HIV patients
• More prevalent in developing countries with poor sanitation
• Transmission: fecal-oral route - contaminated food and water

Pathogenesis & Histopathology

• Primarily infects the proximal small intestine (duodenum/jejunum)
• Causes villous atrophy, crypt hyperplasia, and malabsorption
• Uniquely, organisms can invade beyond the epithelium into the lamina propria (unlike Cryptosporidium and Cyclospora)
• Pathogenesis similar to Cryptosporidium and Cyclospora though less well studied

Clinical Features

• Self-limiting watery diarrhea + abdominal pain lasting 2-4 weeks
• Associated with travel to tropical areas

• Protracted sprue-like illness with:
  • Chronic watery non-bloody diarrhea (may be profuse)
  • Malabsorption and steatorrhea
  • Significant weight loss
  • Prolonged course without treatment

• Peripheral eosinophilia - unique among the coccidia (not seen with Cryptosporidium or Cyclospora)
• Charcot-Leyden crystals in stool (released from eosinophil granules)
• Acalculous cholecystitis - reported in AIDS patients (as with Cryptosporidium and Cyclospora)

Peripheral eosinophilia + Charcot-Leyden crystals in stool = diagnostic clue for Isospora belli

Diagnosis

• Modified acid-fast stain of concentrated stool - large oval oocysts (20-30 µm) with 2 sporocysts
• May require repeated stool samples (minimum 3)
• Stool examination for ova & parasites: must specifically request acid-fast stain
• Small bowel biopsy - oocysts visible in specimens; organisms may be seen in lamina propria
• Oocysts may auto-fluoresce under UV fluorescence microscopy
• PCR available but not widely used clinically

Treatment

• TMP-SMX is highly effective - even in immunocompromised patients (unlike Cryptosporidium)
• Maintenance suppressive therapy required in AIDS to prevent relapse
• Treatment promptly eradicates the organism and relieves symptoms
• Nitazoxanide also appears effective

PART 2: CRYPTOSPORIDIUM

Organism & Taxonomy

• C. hominis - human-restricted (identified as distinct species in 2002)
• C. parvum - wide mammalian tropism (also infects cattle); most common in zoonotic cases
• Others: C. meleagridis, C. felis, C. canis, C. cuniculus

Epidemiology

• One of the most common causes of diarrhea in HIV/AIDS - annual incidence ~5-10%
• Worldwide distribution; stool positivity: 1-22% in resource-limited countries vs. 0.3-4% in industrialized countries
• Second or third most prevalent cause of life-threatening diarrhea in children globally
• Major cause of waterborne outbreaks (responsible for >85% of waterborne diarrheal outbreaks in the USA) - oocysts are highly chlorine-resistant and pass through standard water filters
• In the USA, 444 outbreaks reported by CDC between 2009-2017
• Seropositivity: 15-36% in industrialized countries; up to 65-100% in parts of Latin America

• HIV/AIDS (especially CD4 <200 cells/µL)
• Hypogammaglobulinemia
• Lymphocytic malignancies
• Solid organ transplant recipients on immunosuppression

Life Cycle & Pathogenesis

1. Ingestion of oocysts (infectious dose as low as 1-10 oocysts)
2. Excystation in small intestine - bile salts trigger release of 4 sporozoites per oocyst
3. Sporozoites attach to intestinal epithelium → microvilli elongate and fuse, enclosing the parasite in a parasitophorous vacuole just beneath the brush border (intracellular but extracytoplasmic location)
4. Development: sporozoites → merozoites (asexual replication - merogony)
5. In immunocompetent: second-generation merozoites undergo meiosis → micro/macrogametocytes → fertilization → oocysts shed in feces → ends replication
6. In severely immunocompromised (HIV): parasites continue in asexual cycle indefinitely - basis of chronic, unrelenting infection
7. Oocysts undergo precocious sporulation - can autoinfect the same host (unique among oocyst-forming parasites)
8. Rarely: extraintestinal spread to biliary, respiratory, or conjunctival epithelium in immunocompromised

Morphology

Clinical Features

• Watery, non-bloody diarrhea lasting 1-4 weeks (self-limiting)
• Abdominal cramps, nausea, low-grade fever
• Children < 2 years disproportionately affected in developing countries

• Chronic, watery, profuse diarrhea - can be massive (cholera-like) and fatal
• Up to 3-6 liters/day of watery stool
• Severe malabsorption and wasting
• Course depends on CD4 count:
  • CD4 > 200: may self-resolve
  • CD4 < 50: persistent, life-threatening cholera-like diarrhea with severe wasting

• Biliary cryptosporidiosis - sclerosing cholangitis picture, acalculous cholecystitis, cholangiopathy (AIDS cholangiopathy) - presents with RUQ pain, elevated ALP
• Pulmonary cryptosporidiosis - lower respiratory tract involvement (most common extraintestinal site in HIV/AIDS)
• Pancreatitis (involvement of pancreatic duct)
• Rarely: conjunctival involvement

Diagnosis

• Minimum 3 stool samples (oocyst shedding fluctuates)
• Note: NOT detected on routine O&P exam - must specifically request acid-fast stain or antigen testing

Treatment

The single most important intervention for cryptosporidiosis in HIV is immune reconstitution through ART. Without CD4 recovery, no antiparasitic drug reliably eliminates the infection.

COMPARISON TABLE: Isospora belli vs. Cryptosporidium in HIV

Key Clinical Pearls

1. Isospora in AIDS = TMP-SMX - same drug used for PCP prophylaxis, which also provides protection against Isospora; TMP-SMX is reliably effective even in AIDS.
2. Cryptosporidium in AIDS = treat the HIV first - no antiparasitic drug is reliably effective without immune reconstitution via ART. This is the most important clinical point.
3. Both organisms cause acalculous cholecystitis in AIDS. Cryptosporidium is a more common cause of full AIDS cholangiopathy (sclerosing cholangitis pattern).
4. Eosinophilia in a patient with AIDS + chronic diarrhea = Isospora belli until proven otherwise (not seen with Cryptosporidium or Giardia).
5. CD4 thresholds: Both infections are more severe at CD4 < 200; Cryptosporidium becomes cholera-like at CD4 < 50.
6. Diagnosis of both requires specifically requesting modified acid-fast stain - they are missed on routine O&P.
7. Cryptosporidium's unique intracellular but extracytoplasmic location (beneath the brush border) explains why many drugs that work intracellularly are ineffective.